MENU
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
61.99B
P/E Ratio
14.59
Total Cash
8.35B
Projected Growth
1.24
Total Debt
2.7B
Revenue
14.09B
Risk (Beta)
0.33
Dividend Yield
0.00
Total Cash/Share
77.33
Total Debt/Equity
24.02
Revenue/Share
123.42 USD as % of share price
Fundamentals
REGN
Capitalization
62B
P/E Ratio
14.59
Risk (Beta)
0.33
Dividend Yield
0.00
Total Cash
8.35B
Total Cash/Share
77.33
Total Debt
2.71B
Total Debt/Equity
24.02
Projected Growth (PEG Ratio)
1.24
Revenue/Share (as % of the share price)
123.42%
Revenue
14.1B
ROE
N/A
Book Value
29.4B
P/B Ratio
2.11
Cash Flow
N/A
Earnings
41.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
4.93
Current Revenue Per Employee
199808.69
Dividends Per Share - Security
0.88
EBITDA
5.53B
Float
N/A
Float - Current
N/A
Gross Income Margin
84.67
Revenue To Assets
12.51
Shares Held By Institutions
205B
Shares Outstanding - Current
108M
Total Liabilities
8.16B
Total Volume MTD
N/A
Value
1
Gain YTD
-19.293
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of medicines for the treatment of serious medical conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com